Shenzhen, Guangdong, China Related Funds
| Fund Name | Location |
| Amethis Finance | France, Ile-de-France, Paris |
| and factory | Japan, Tokyo |
| Blue Shield of California | California, San Francisco, United States |
| Cemex Ventures | Madrid, Madrid, Spain |
| Chuguan Touzi | China, Jiading District |
| Hekikai Shinkin Bank | Aichi Prefecture, Anjo, Japan |
| Jiahesheng Maoyi | China, Fujian, Zhangpu |
| Leyu Tianqi Culture Communication | - |
| M-Investar | Bayern, Germany, Isen |
| Neon Capital | - |
| Newton Fund | California, San Francisco, United States |
| Qingke Huacheng Investment | China, Guangdong, Shenzhen |
| Ray Carriers | - |
| Red Hook Capital | California, Sunnyvale, United States |
| Season Two Ventures | Bengaluru, India, Karnataka |
| The Ashforth Company | Connecticut, Stamford, United States |
| TIAN JIAN | Beijing, Beijing, China |
| Turtle Entertainment | Cologne, Germany, Nordrhein-Westfalen |
| Zesheng Ziben | China, Guangdong, Tianjin |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Beimei Pharmaceutical | $15M | 02 Apr 2022 | Shenzhen, Guangdong, China | ||
Linkapp.cn | $463K | 20 Sep 2016 | Haidian District, Beijing, China | ||
WEFANS | $2M | 29 Jul 2015 | Futian District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Beimei Pharmaceutical | $15M | 02 Apr 2022 | Shenzhen, Guangdong, China | ||
Linkapp.cn | $463K | 20 Sep 2016 | Haidian District, Beijing, China | ||
WEFANS | $2M | 29 Jul 2015 | Futian District, Guangdong Province, China |
